These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 23183104)

  • 1. Are membrane proteins favored over cytosolic proteins in TAP-independent processing pathways?
    Del Val M; Lázaro S; Ramos M; Antón LC
    Mol Immunol; 2013 Sep; 55(2):117-9. PubMed ID: 23183104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting tumour cells with defects in the MHC Class I antigen processing pathway with CD8+ T cells specific for hydrophobic TAP- and Tapasin-independent peptides: the requirement for directed access into the ER.
    Aladin F; Lautscham G; Humphries E; Coulson J; Blake N
    Cancer Immunol Immunother; 2007 Aug; 56(8):1143-52. PubMed ID: 17143611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination and the TAP-independent antigen processing pathways.
    López D; Lorente E; Barriga A; Johnstone C; Mir C
    Expert Rev Vaccines; 2013 Sep; 12(9):1077-83. PubMed ID: 24053400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A viral, transporter associated with antigen processing (TAP)-independent, high affinity ligand with alternative interactions endogenously presented by the nonclassical human leukocyte antigen E class I molecule.
    Lorente E; Infantes S; Abia D; Barnea E; Beer I; García R; Lasala F; Jiménez M; Mir C; Morreale A; Admon A; López D
    J Biol Chem; 2012 Oct; 287(42):34895-34903. PubMed ID: 22927436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of TAP-independent processing pathways.
    Oliveira CC; van Hall T
    Mol Immunol; 2013 Sep; 55(2):113-6. PubMed ID: 23183105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Features of TAP-independent MHC class I ligands revealed by quantitative mass spectrometry.
    Weinzierl AO; Rudolf D; Hillen N; Tenzer S; van Endert P; Schild H; Rammensee HG; Stevanović S
    Eur J Immunol; 2008 Jun; 38(6):1503-10. PubMed ID: 18446792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous TAP-independent MHC-I antigen presentation: not just the ER lumen.
    Del Val M; Antón LC; Ramos M; Muñoz-Abad V; Campos-Sánchez E
    Curr Opin Immunol; 2020 Jun; 64():9-14. PubMed ID: 31935516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An epitope-selective, transporter associated with antigen presentation (TAP)-1/2-independent pathway and a more general TAP-1/2-dependent antigen-processing pathway allow recognition of the HIV-1 envelope glycoprotein by CD8+ CTL.
    Hammond SA; Johnson RP; Kalams SA; Walker BD; Takiguchi M; Safrit JT; Koup RA; Siliciano RF
    J Immunol; 1995 Jun; 154(11):6140-56. PubMed ID: 7538543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational characterization of the peptidome in transporter associated with antigen processing (TAP)-deficient cells.
    Martín-Galiano AJ; López D
    PLoS One; 2019; 14(1):e0210583. PubMed ID: 30645615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TAP-mediated processing of exoerythrocytic antigens is essential for protection induced with radiation-attenuated Plasmodium sporozoites.
    Pichugin A; Steers N; De La Vega P; Zarling S; Chalom I; Krzych U
    Eur J Immunol; 2016 Apr; 46(4):885-96. PubMed ID: 26703789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Existence of MHC class I-restricted alloreactive CD4+ T cells reacting with peptide transporter-deficient cells.
    Kobayashi H; Kimura S; Aoki N; Sato K; Celis E; Katagiri M
    Immunogenetics; 2001 Oct; 53(8):626-33. PubMed ID: 11797095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
    Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
    Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accessory molecules in the assembly of major histocompatibility complex class I/peptide complexes: how essential are they for CD8(+) T-cell immune responses?
    Garbi N; Tanaka S; van den Broek M; Momburg F; Hämmerling GJ
    Immunol Rev; 2005 Oct; 207():77-88. PubMed ID: 16181328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol.
    Luckey CJ; King GM; Marto JA; Venketeswaran S; Maier BF; Crotzer VL; Colella TA; Shabanowitz J; Hunt DF; Engelhard VH
    J Immunol; 1998 Jul; 161(1):112-21. PubMed ID: 9647214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ongoing saga of the mechanism(s) of MHC class I-restricted cross-presentation.
    Grotzke JE; Sengupta D; Lu Q; Cresswell P
    Curr Opin Immunol; 2017 Jun; 46():89-96. PubMed ID: 28528219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells.
    Guermonprez P; Saveanu L; Kleijmeer M; Davoust J; Van Endert P; Amigorena S
    Nature; 2003 Sep; 425(6956):397-402. PubMed ID: 14508489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Processing of HIV-1 envelope glycoprotein for class I-restricted recognition: dependence on TAP1/2 and mechanisms for cytosolic localization.
    Ferris RL; Hall C; Sipsas NV; Safrit JT; Trocha A; Koup RA; Johnson RP; Siliciano RF
    J Immunol; 1999 Feb; 162(3):1324-32. PubMed ID: 9973386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TAP peptide transporter-independent presentation of heat-killed Sendai virus antigen on MHC class I molecules by splenic antigen-presenting cells.
    Liu T; Chambers B; Diehl AD; Van Kaer L; Jondal M; Ljunggren HG
    J Immunol; 1997 Dec; 159(11):5364-71. PubMed ID: 9548476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAP-independent self-peptides enhance T cell recognition of immune-escaped tumors.
    Doorduijn EM; Sluijter M; Querido BJ; Oliveira CC; Achour A; Ossendorp F; van der Burg SH; van Hall T
    J Clin Invest; 2016 Feb; 126(2):784-94. PubMed ID: 26784543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple proteases process viral antigens for presentation by MHC class I molecules to CD8(+) T lymphocytes.
    Del-Val M; López D
    Mol Immunol; 2002 Oct; 39(3-4):235-47. PubMed ID: 12200053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.